Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Marcello Tiseo

"Pseudocavitation" in thymic carcinoma during treatment with sunitinib.

scientific article published on April 2013

'Turban-like' skull metastasis from pulmonary adenocarcinoma

scientific article

2PD Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC.

scientific article published on 15 April 2016

A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors

scientific article published on 31 May 2020

A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?

scientific article published on 01 March 2020

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

scientific article published on 27 February 2019

A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer

scientific article

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients

scientific article published on 7 July 2015

ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".

scientific article published in December 2017

Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer

article

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

scientific article published on 25 July 2009

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors

scientific article published on 16 August 2014

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

scientific article published on 16 September 2020

Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?

scientific article

Advantages of multidetector-row CT with multiplanar reformation in guiding percutaneous lung biopsies

scientific article published on 25 September 2008

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

scientific article

Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).

scientific article published on 14 December 2016

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

scientific article

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient.

scientific article

Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients

article

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

scientific article published on 26 February 2016

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

scientific article published on 01 July 2014

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall.

scientific article

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

scientific article published on 5 May 2017

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer

scientific article published on 25 September 2018

Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer

scientific article published in November 2007

CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients

scientific article published on 3 March 2015

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

scientific article published on 12 June 2020

CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage?

scientific article published on September 2014

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

scientific article published on 22 October 2020

Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer

scientific article

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

scientific article published in June 2007

Classification of different patterns of pulmonary adenocarcinomas.

scientific article published on 27 August 2015

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab

scientific article published on 01 June 2018

Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements.

scientific article published on March 2015

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

scientific article published on 30 May 2020

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation

scientific article published on 19 March 2016

Combination of target agents: challenges and opportunities.

scientific article published on May 2007

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

scientific article published on 10 July 2017

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

scientific article published on 12 December 2012

Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites

scientific article published on January 2008

Concomitant EGFR and KRAS mutations in ALK-rearranged lung cancer

scientific article published on 10 February 2015

Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC.

scientific article published on 26 March 2018

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.

scientific article published on 20 January 2016

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC).

scientific article published on 12 December 2013

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients

scientific article published on 7 June 2011

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Crizotinib Resensitization by Compound Mutation

scientific article

Current status of second-line treatment and novel therapies for small cell lung cancer.

scientific article published on August 2007

Curved Needles in CT-Guided Fine Needle Biopsies of Abdominal and Retroperitoneal Small Lesions

scientific article published on 25 April 2015

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

scientific article published in December 2006

Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment.

scientific article

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

scientific article

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

scientific article published on 19 December 2014

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.

scientific article published on 12 February 2018

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome

scientific article published on 13 April 2016

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

scientific article published on 22 April 2015

Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series.

scientific article

EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations

scientific article published on 18 December 2010

EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.

scientific article

EPMA-World Congress 2015

scientific article

ERCC1 and small cell lung cancer

scientific article published on 01 November 2010

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

scientific article published on 2 April 2013

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

scientific article

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

scientific article published on 16 November 2020

Efficacy and safety of influenza vaccination during chemotherapy treatment

scientific article published on 01 November 2010

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

scientific article published on 23 October 2017

Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.

scientific article published on March 2015

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.

scientific article

Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib

scientific article published on 22 December 2020

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC).

scientific article

Endometrial metastasis of lung adenocarcinoma: a case report

scientific article published in May 2011

Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN

scientific article published on 23 May 2017

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

scientific article published on 17 July 2017

Enteral administration of TKIs: report of a response to ceritinib in an ALK-positive NSCLC patient and literature review

scientific article published on 12 February 2018

Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples

scientific article

Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.

scientific article published on March 2004

Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer

scientific article published in October 2008

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

scientific article published in August 2003

Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer

scientific article published on January 2013

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

scientific article published on 07 January 2020

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines

scientific article

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines

Expert opinions of the first italian consensus conference on the management of malignant pleural mesothelioma

scientific article published on February 2011

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

scientific article

Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer.

scientific article published on 23 March 2010

Extra-pleuric coaxial system for CT-guided percutaneous fine-needle aspiration biopsy (FNAB) of small (≤20 mm) lung nodules: a novel technique using multiplanar reconstruction (MPR) images.

scientific article

FGFR as potential target in the treatment of squamous non small cell lung cancer

scientific article published on May 2015

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

scientific article published on 22 March 2018

First-line chemotherapy treatment of advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

scientific article published on 01 November 2014

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

scientific article published on April 2009

Fishing for ALK with immunohistochemistry may predict response to crizotinib

scientific article

Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines.

scientific article published on 2 April 2010

Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification

scientific article (publication date: 2013)

Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients

scientific article published on 12 October 2014

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

scientific article published on 16 December 2013

Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).

scientific article

How to develop novel treatments for EGFR-mutant lung cancer.

scientific article published on 13 August 2015

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

scientific article published on 01 February 2020

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.

scientific article

Induction chemotherapy with carboplatin-paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer

scientific article published on 01 February 2005

Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations

scientific article published on 26 May 2015

Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer?

scientific article published in April 2010

Is immunohistochemistry always required to diagnose lung cancer?

scientific article published on September 2013

Is the door open to further investigation with antiangiogenesis in SCLC?

scientific article

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

scientific article published on 16 November 2015

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)

article

Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population

scientific article published on 20 May 2016

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

scientific article published on 28 September 2014

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice

scientific article

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.

scientific article published on 30 January 2017

K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature

scientific article published on 11 January 2016

L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.

scientific article published on 30 May 2016

L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib

scientific article

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

scientific article published on 25 September 2019

Localized Malignant Pleural Mesothelioma: Report of Two Cases

scientific article published in August 2009

Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

scientific article published on 26 October 2017

Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.

scientific article published on 28 October 2017

MET DNA Alterations in NSCLC-Letter

scientific article published in July 2016

MET and ALK as targets for the treatment of NSCLC.

scientific article published on January 2014

MET and Small-Cell Lung Cancer

scientific article

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

scientific article

Maintenance therapy in NSCLC: why? To whom? Which agent? ⬇️

scientific article

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach

scientific article published on 13 November 2019

Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer

scientific article published on 23 March 2017

Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report.

scientific article

Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.

scientific article

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).

scientific article

MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.

scientific article published on 3 July 2017

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

scientific article published on 16 June 2017

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.

scientific article published on 8 June 2016

Multi-target inhibitors in non-small cell lung cancer (NSCLC).

scientific article

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study

scientific article published on 13 October 2020

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 09 May 2018

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

scientific article published on 13 August 2013

Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma

scientific article published on 21 November 2019

No room for statins in the quest for survival benefits in small cell lung cancer

scientific article

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition

scientific article published on 12 March 2017

Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.

scientific article published on 19 September 2015

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

scientific article

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

scientific article published on 24 April 2015

Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report

scientific article published in January 2014

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

scientific article published on 13 December 2019

Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment.

scientific article published on 15 September 2017

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report.

scientific article

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

article

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.

scientific article published on 11 August 2012

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

scientific article published on 14 December 2017

Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer

scientific article published on 08 October 2013

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

scientific article published on 01 September 2005

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.

scientific article published in January 2008

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.

scientific article

Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules.

scientific article published on 25 July 2013

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

scientific article

Predictors of clinical response of non-small cell cancer to gefitinib

scientific article published in April 2004

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.

scientific article published on 26 May 2009

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

scientific article

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan

scientific article published on 02 August 2014

Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma

scientific article published in April 2012

Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors

scientific article published on August 2015

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.

scientific article published on 27 July 2016

Refractory pleural small cell carcinoma in never smoker. A case report.

scientific article published in May 2008

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer

scientific article

Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.

scientific article

Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?

scientific article published on 01 May 2015

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

scientific article

Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

scientific article

Semiautomatic Analysis on Computed Tomography in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Unidimensional and 3-dimensional Measurements

scientific article published on 26 March 2015

Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma

scientific article published on 01 March 2007

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

scientific article

Targeting the MET gene for the treatment of non-small-cell lung cancer

scientific article published on December 2013

The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors

scientific article published on 12 May 2020

The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies

scientific article published on 04 December 2019

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

scientific article

Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC

Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance.

scientific article

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.

scientific article published on 4 December 2017

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

scientific article

Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.

scientific article

Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.

scientific article published on 30 April 2015

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

scientific article published on 12 January 2012

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report

scientific article

Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trials

scientific article published on 26 June 2014

Widespread Nivolumab-induced Enteropathy in a Long Responder Non–Small-cell Lung Cancer Patient

scientific article published in September 2018

YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis

scientific article published in December 2013

Paulina is supported by:

About Paulina

Help